New Senate Bills To Streamline Device Modifications, Expand HDEs Align With House Provisions
This article was originally published in The Gray Sheet
Executive Summary
Two industry-supported bills introduced in the Senate parallel provisions in the 21st Century Cures bill passed by the House in July. One would allow third-party quality-system certification to supplant premarket submissions for certain modifications and another would expand the humanitarian device exemption program.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
Takeda, Astellas Found New JV To Support Japanese Bioventures
Major Japanese companies Takeda, Astellas and SMBC are joining hands to establish a new joint venture with $3.9m capital and based in Japan’s largest biocluster Shonan iPark to help incubate local biopharma start-ups.
Could Eledon’s Anti-CD40L Change Transplant Medicine?
Eledon Pharmaceuticals’ CD40 Ligand blocker has yielded impressive results for post-transplant immunosuppression and cutting-edge transplant doctors have also used it for pig-to-human kidney and heart transplants, opening up the field of xenotransplantation.